BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 15994368)

  • 1. N-methyl-N'-nitro-N-nitrosoguanidine activates cell-cycle arrest through distinct mechanisms activated in a dose-dependent manner.
    Beardsley DI; Kim WJ; Brown KD
    Mol Pharmacol; 2005 Oct; 68(4):1049-60. PubMed ID: 15994368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methylator-induced, mismatch repair-dependent G2 arrest is activated through Chk1 and Chk2.
    Adamson AW; Beardsley DI; Kim WJ; Gao Y; Baskaran R; Brown KD
    Mol Biol Cell; 2005 Mar; 16(3):1513-26. PubMed ID: 15647386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA damage induced by temozolomide signals to both ATM and ATR: role of the mismatch repair system.
    Caporali S; Falcinelli S; Starace G; Russo MT; Bonmassar E; Jiricny J; D'Atri S
    Mol Pharmacol; 2004 Sep; 66(3):478-91. PubMed ID: 15322239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mismatch repair-dependent G2 checkpoint induced by low doses of SN1 type methylating agents requires the ATR kinase.
    Stojic L; Mojas N; Cejka P; Di Pietro M; Ferrari S; Marra G; Jiricny J
    Genes Dev; 2004 Jun; 18(11):1331-44. PubMed ID: 15175264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The alkylating carcinogen N-methyl-N'-nitro-N-nitrosoguanidine activates the plasminogen activator inhibitor-1 gene through sequential phosphorylation of p53 by ATM and ATR kinases.
    Vidal B; Parra M; Jardí M; Saito S; Appella E; Muñoz-Cánoves P
    Thromb Haemost; 2005 Mar; 93(3):584-91. PubMed ID: 15735814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CHK1 and CHK2 are differentially involved in mismatch repair-mediated 6-thioguanine-induced cell cycle checkpoint responses.
    Yan T; Desai AB; Jacobberger JW; Sramkoski RM; Loh T; Kinsella TJ
    Mol Cancer Ther; 2004 Sep; 3(9):1147-57. PubMed ID: 15367709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resveratrol causes Cdc2-tyr15 phosphorylation via ATM/ATR-Chk1/2-Cdc25C pathway as a central mechanism for S phase arrest in human ovarian carcinoma Ovcar-3 cells.
    Tyagi A; Singh RP; Agarwal C; Siriwardana S; Sclafani RA; Agarwal R
    Carcinogenesis; 2005 Nov; 26(11):1978-87. PubMed ID: 15975956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carcinogen-induced S-phase arrest is Chk1 mediated and caffeine sensitive.
    Guo N; Faller DV; Vaziri C
    Cell Growth Differ; 2002 Feb; 13(2):77-86. PubMed ID: 11864911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ATM is activated in response to N-methyl-N'-nitro-N-nitrosoguanidine-induced DNA alkylation.
    Adamson AW; Kim WJ; Shangary S; Baskaran R; Brown KD
    J Biol Chem; 2002 Oct; 277(41):38222-9. PubMed ID: 12151394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-methyl-N'-nitro-N-nitrosoguanidine activates multiple cell death mechanisms in human fibroblasts.
    Lee MW; Kim WJ; Beardsley DI; Brown KD
    DNA Cell Biol; 2007 Sep; 26(9):683-94. PubMed ID: 17678437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MLH1- and ATM-dependent MAPK signaling is activated through c-Abl in response to the alkylator N-methyl-N'-nitro-N'-nitrosoguanidine.
    Kim WJ; Rajasekaran B; Brown KD
    J Biol Chem; 2007 Nov; 282(44):32021-31. PubMed ID: 17804421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of c-Abl kinase in DNA mismatch repair-dependent G2 cell cycle checkpoint arrest responses.
    Wagner MW; Li LS; Morales JC; Galindo CL; Garner HR; Bornmann WG; Boothman DA
    J Biol Chem; 2008 Aug; 283(31):21382-93. PubMed ID: 18480061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-methyl-N'-nitro-N-nitrosoguanidine-induced senescence-like growth arrest in colon cancer cells is associated with loss of adenomatous polyposis coli protein, microtubule organization, and telomeric DNA.
    Jaiswal AS; Multani AS; Pathak S; Narayan S
    Mol Cancer; 2004 Jan; 3():3. PubMed ID: 14728717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mammalian Chk2 is a downstream effector of the ATM-dependent DNA damage checkpoint pathway.
    Chaturvedi P; Eng WK; Zhu Y; Mattern MR; Mishra R; Hurle MR; Zhang X; Annan RS; Lu Q; Faucette LF; Scott GF; Li X; Carr SA; Johnson RK; Winkler JD; Zhou BB
    Oncogene; 1999 Jul; 18(28):4047-54. PubMed ID: 10435585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The monofunctional alkylating agent N-methyl-N'-nitro-N-nitrosoguanidine triggers apoptosis through p53-dependent and -independent pathways.
    Kim WJ; Beardsley DI; Adamson AW; Brown KD
    Toxicol Appl Pharmacol; 2005 Jan; 202(1):84-98. PubMed ID: 15589979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of ATM/ATR-p38 MAPK cascade in MNNG induced G1-S arrest.
    Zhu KQ; Zhang SJ
    World J Gastroenterol; 2003 Sep; 9(9):2073-7. PubMed ID: 12970909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for a connection between the mismatch repair system and the G2 cell cycle checkpoint.
    Hawn MT; Umar A; Carethers JM; Marra G; Kunkel TA; Boland CR; Koi M
    Cancer Res; 1995 Sep; 55(17):3721-5. PubMed ID: 7641183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of the ATR- and ATM-dependent checkpoint responses in cell cycle arrest evoked by pierisin-1.
    Shiotani B; Kobayashi M; Watanabe M; Yamamoto K; Sugimura T; Wakabayashi K
    Mol Cancer Res; 2006 Feb; 4(2):125-33. PubMed ID: 16513843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ATR-CHK1-E2F3 signaling transactivates human ribonucleotide reductase small subunit M2 for DNA repair induced by the chemical carcinogen MNNG.
    Gong C; Liu H; Song R; Zhong T; Lou M; Wang T; Qi H; Shen J; Zhu L; Shao J
    Biochim Biophys Acta; 2016 Apr; 1859(4):612-26. PubMed ID: 26921499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mismatch repair-mediated G2/M arrest by 6-thioguanine involves the ATR-Chk1 pathway.
    Yamane K; Taylor K; Kinsella TJ
    Biochem Biophys Res Commun; 2004 May; 318(1):297-302. PubMed ID: 15110787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.